Businessman pushing acquisition button pichet_w/ThinkstockPhotos

ADM to acquire probiotic supplement company

Probiotics International Limited has sales into more than 60 countries.

Archer Daniels Midland Company has reached an agreement to acquire Probiotics International Limited, a U.K.-based provider of probiotic supplements for human, pet, and production-animal use. The all-cash transaction will be valued at £185 million, subject to customary adjustments. 

“ADM is already one of the world’s largest providers of human and animal nutrition solutions, and the acquisition of PIL will add to our extensive portfolio of products that promote health and wellness,” said Vikram Luthar, president, ADM Health & Wellness. “We took a major step in this area last year with the addition of Biopolis, and then added to our capabilities with our personalized nutrition collaboration with Mayo Clinic, our joint development agreement with Vland Biotech, and our new enzyme lab in California. Now, with the addition of PIL’s extensive sales and marketing network to our existing R&D capabilities, we are building a world class, fully integrated probiotics and nutraceuticals business.”

PIL, based in Somerset, U.K. — and known under its umbrella brand Protexin — is a provider of probiotic supplements for human wellness and animal markets, including aquaculture, equine, livestock and companion animals. PIL produces the Bio-Kult brand of probiotic supplements along with contract-manufactured products. The company has about 160 employees with sales into more than 60 countries.

“PIL has created market-leading brands in the veterinary, equine and human health markets around the world, and we are delighted to join ADM’s Health and Wellness business. We very much look forward to building on this success,” said Jonathan Sowler, PIL commercial director. “There are great synergies with ADM and Biopolis, especially in the area of R&D, and we plan to add to an already very exciting development pipeline to provide innovative, evidence-based products of the highest quality for people and animals.”

The deal, which is subject to regulatory review, is expected to close in the third quarter. 

Source: ADM

 

 

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish